Clinical trials in oncology are complex. And urgent. For those individuals fighting cancer, the opportunity to enroll in a trial is often later on in their treatment pathway, meaning such trials bring with them considerable safety concerns and the need to collect and monitor a large amount of data. These data are increasingly coming in from a number of sources, both in-clinic and through decentralized mechanisms.
Consequently, modern oncology clinical trials need a robust mechanism to collate and process these data, and to do so quickly, enabling clinical research associates (CRAs) to be alerted to potentially concerning data as fast as possible.
In this webinar, attendees will learn how Labcorp Oncology, with its 30+ years of experience as a CRO, has developed a centralized data processing mechanism that enables it to derive actionable insights from data as soon as it becomes available, to monitor quality and patient-level information and present it in aggregated form to show trends and patterns per outcome.
Join our featured speaker to learn how this mechanism, together with the combined capabilities of an experienced medical, scientific and regulatory team, is accelerating oncology product development.
Ariel E. Aguiló, MD, Executive Medical Director and Head of the Americas Oncology Medical Team, Labcorp Oncology
Ariel Aguiló, MD, Executive Medical Director and Head of the Americas Oncology Medical Team, Labcorp Oncology in Buenos Aires, Argentina, is a board-certified oncologist specialized in gastrointestinal tumors. He provides subject matter expertise and support for the development and conduct of clinical trials on clients’ drug development projects, including serving as the company’s subject matter expert for decentralized clinical trials (DCT). Dr. Aguiló performs medical monitoring on assigned projects, contributes to the medical strategy and execution of clinical programs, and brings scientific strategic leadership to the Oncology area at Labcorp Drug Development.
He has 10 years of experience as a physician, medical advisor and medical director in drug research and development. Before joining Labcorp, he served as Medical Director for Syneos Health in Buenos Aires, and prior to that, served as Medical Advisor for IQVIA in Buenos Aires. Dr. Aguiló began his career as Attending Physician, GI Oncology Department, Hospital de Gastroenterologia. He joined Labcorp in November 2019.Message Presenter
Who Should Attend?
This webinar will benefit professionals working in oncology drug development (including precision medicine, cell and gene therapies and immuno-oncology products) at biotech companies, with relevant job areas including:
- Clinical Research Coordinators
- Medical Leads
- Oncology Product Delivery
What You Will Learn
Join this webinar for a demonstration of how the development of a centralized data processing solution enables near-real-time review of oncology clinical trial data, regardless of source (e.g., in-clinic, decentralized, remote, wearables, etc.). Key topics will include how this solution:
- Helps understand unmet needs about digital measures in oncology
- Improves data quality and patient safety in trials
- Expands the use of decentralized techniques where delayed data analysis reviews would otherwise prohibit their use
- Provides data aggregation and trend review
- Improves connection between medical reviewer, CRA and patient
- Establishes a solid foundation for the addition of artificial intelligence (AI) computing into complex trials
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. Learn more about Labcorp at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.